Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics Inc. - Common Stock
(NQ:
ABEO
)
5.070
-0.080 (-1.55%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abeona Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
Next >
Keep an eye on the top gainers and losers in Wednesday's session.
↗
November 12, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 12, 2025
Via
Benzinga
Here's Why Abeona Therapeutics Popped Higher Today
↗
November 12, 2025
This company is making excellent progress on its treatment for a very rare and serious skin disorder.
Via
The Motley Fool
There are notable gap-ups and gap-downs in today's session.
↗
November 12, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Abeona Therapeutics (NASDAQ:ABEO) Stock Falls on Revenue Miss Despite Q3 EPS Beat
↗
November 12, 2025
Abeona Therapeutics beat Q3 EPS estimates but missed on revenue. The stock fell as investors focus on the delayed launch of its new gene therapy, ZEVASKYN.
Via
Chartmill
What to Expect from Abeona Therapeutics's Earnings
↗
November 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 16, 2025
Via
Benzinga
Abeona Posts Q2 Profit on Asset Sale
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
May 27, 2025
Via
Benzinga
Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
↗
May 27, 2025
Via
Benzinga
Which stocks have an unusual volume on Thursday?
↗
May 01, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Wednesday's session: top gainers and losers
↗
April 30, 2025
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Abeona Surges After FDA Clears First Gene Therapy For Severe Genetic Skin Disease
↗
April 30, 2025
Abeona's Zevaskyn secures timely FDA nod, priced at $3.1 million, with 2025 sales now forecast at $31.6 million and peak U.S. revenue projected at $600 million.
Via
Benzinga
Abeona Stock Surges to 52-Week High: What's Behind The Move?
↗
April 30, 2025
Abeona shares are trading higher on Wednesday on possible continued strength after the FDA announced approval for its gene therapy.
Via
Benzinga
Top stock movements in today's session.
↗
April 30, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 30, 2025
Via
Benzinga
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
↗
April 29, 2025
FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
Via
Benzinga
Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease
↗
April 29, 2025
ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy.
Via
Stocktwits
This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
↗
March 05, 2025
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Beats EPS for Q2 2024
↗
August 12, 2024
ABEO stock results show that Abeona Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
May 30, 2024
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024
↗
May 15, 2024
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Crude Oil Moves Higher; General Motors Earnings Top Views
↗
April 23, 2024
Via
Benzinga
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 23, 2024
Via
Benzinga
Dow Jumps Over 200 Points; US Services PMI Falls In April
↗
April 23, 2024
Via
Benzinga
Topics
Stocks
Why Is Affirm (AFRM) Stock Moving Today?
↗
April 23, 2024
Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores.
Via
InvestorPlace
US Stocks Higher; PepsiCo Posts Upbeat Earnings
↗
April 23, 2024
Via
Benzinga
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
↗
April 23, 2024
Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
